Bicarbonate

Bicarbonate

SCHEMBL3704950

O=C(NCc1ccccc1)C(c1ccc(CN2N=C(c3ccc(Cl)cc3)OCC2=O)cc1)C1CCCC1.O=C(O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
C3AR1 Q16581 1/20 0.41
BDKRB2 P30411 1/20 0.41
PTGES O14684 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
MAOB P27338 1/20 0.39
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL1079990 0.95 BDKRB2 (0.43) C3AR1BDKRB2TP53
SCHEMBL1179323 0.93 CNR1 (0.39) C3AR1BDKRB2PTGESMAOB
Bicarbonate SCHEMBL3695270 0.91 PTGES (0.41) BDKRB2PTGESMAOB
SCHEMBL1079989 0.89 BDKRB2 (0.41) BDKRB2MAOBTP53
SCHEMBL12872101 0.89 BDKRB2 (0.41) C3AR1BDKRB2PTGESTP53
SCHEMBL1177950 0.89 PDE4A (0.40) C3AR1PTGESMAOBHPGD
Bicarbonate SCHEMBL3693843 0.89 BDKRB2 (0.41) C3AR1BDKRB2TP53
SCHEMBL1178266 0.88 BDKRB2 (0.41) BDKRB2PTGESTP53
SCHEMBL12871694 0.87 BDKRB2 (0.40) BDKRB2PTGESHPGDTP53
SCHEMBL1081746 0.87 BDKRB2 (0.40) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268625-B1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF Bayer Pharma AG (DE) 2012-05-16 EP disclosed